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Case Report Rapport de cas
Management of bilateral idiopathic renal hematuria in a dog with silver nitrate
Michael F. Di Cicco, Tara Fetzer, Patricia L. Secoura, Kieri Jermyn, Tracy Hill, Serge Chaloub,  
Shelly Vaden
Abstract — Renal hematuria has limited treatment options. This report describes management of bilateral 
idiopathic renal hematuria in a dog with surgically assisted installation of 0.5% silver nitrate solution. Initial 
treatment resulted in freedom from clinical signs or recurrent anemia for 10 months; however, recurrence of 
bleeding following a nephrectomy resulted in euthanasia.
Résumé — Gestion de l’hématurie rénale idiopathique bilatérale chez un chien à l’aide du nitrate d’argent. 
L’hématurie rénale offre des options de traitement limitées. Ce rapport décrit la gestion de l’hématurie rénale 
idiopathique bilatérale chez un chien à l’aide de l’installation assistée par chirurgie d’une solution de nitrate d’argent 
de 0,5 %. Le traitement initial a produit une disparition des signes cliniques ou de l’anémie récurrente pendant 
10 mois. Cependant, la récurrence des saignements après une néphrectomie se sont traduits par l’euthanasie.
(Traduit par Isabelle Vallières)
Can Vet J 2013;54:761–764
I diopathic renal hematuria is a diagnosis of exclusion, char-acterized by gross hematuria in the absence of an obvious 
source or mechanism for bleeding (1). Diagnosis requires direct 
visualization of the urinary tract via laparotomy, cystotomy, or 
cystoscopy as well as obtaining a sample of urine from each 
ureter. The incidence of unexplained renal hematuria in humans 
is estimated to be between 5% and 10% (2) and is believed to 
be uncommon in veterinary medicine.
Clinical signs vary from an incidental finding of microscopic or 
macroscopic hematuria to a severe anemia, ureteral and urethral 
obstruction, or death (3–6). Thirteen of the 17 cases reported in 
the veterinary literature were unilateral with a favorable outcome 
following nephrectomy (12/13) or benign neglect (1/13); how-
ever, the remaining bilateral cases resulted in death or euthanasia 
(1,4–8). The prevalence of bilateral involvement is unknown.
Case description
An 11.5-year-old spayed female American Eskimo dog was 
referred to the Veterinary Health Complex, North Carolina State 
University (VHC NCSU) for gross hematuria of 1 mo duration. 
Previous assessments included laboratory evaluation [complete 
blood cell count (CBC), reticulocyte count, serum biochemistry 
profile, urinalysis, urine culture, prothrombin time, activated 
partial thrombin time, and buccal mucosal bleeding time], 
abdominal ultrasonography, and cystotomy. Abnormal results 
included a regenerative anemia [hematocrit (HCT) 23.4%, 
reference range (RR): 36% to 60%; reticulocytosis 207 000, 
reference value: , 6000; nucleated red blood cells (nRBC) 
2/100 white blood cells (WBC)], decreased blood urea nitro-
gen (BUN); (1.4 mmol/L, RR: 2.5 to 9.6 mmol/L), increased 
alanine aminotransferase (ALT; 184 U/L, RR: 10 to 100 U/L), 
increased alkaline phosphatase (ALKP; 300 U/L, RR: 23 to 
212 U/L), and hematuria [. 50 RBC/high power field (hpf ) 
reference value: 0]. Results of all coagulation tests were within 
the reference ranges. Findings during a focal urinary bladder 
ultrasound were consistent with, although not diagnostic for, a 
bladder wall mass. During cystotomy a thickened, hyperemic 
urinary bladder wall and a 2 to 3 cm dark red mass were found. 
Results of histopathologic evaluation of the mass were consistent 
with a blood clot.
On presentation to the VHC NCSU, the dog was quiet, 
alert, and responsive with a grade II/VI left basilar systolic 
heart murmur, bounding femoral pulses, and a healing ventral 
midline incision. Results of a CBC and limited biochemi-
cal panel disclosed a regenerative anemia (HCT 22.7%; 
385 000 reticulocytes, reference value: , 6000), monocytosis 
(1.075 3 103/UL, RR: 0.075 to 0.85 3 103/UL), decreased 
creatinine (53.0 mmol/L, RR: 61.9 to 132.6 mmol/L), hypoalbu-
minemia (29 g/L, RR: 30 to 39 g/L), and decreased bicarbonate 
(17 mmol/L, RR: 18 to 25.8 mmol/L). Ultrasonography of the 
urinary tract revealed a thickening of the cranioventral bladder 
wall, attributed to the previous cystotomy. The bladder lumen 
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contained layered hyperechoic material consistent with blood 
clots. Both kidneys contained small cortical cysts, and had nor-
mal vasculature and flow; kidney sizes were within the reference 
range (RR: 3.2 cm to 6.4 cm for dogs weighing 5 to 14 kg). 
Three-view thoracic radiographs were normal. The dog received 
a packed red blood cell (pRBC) transfusion (10 mL/kg BW over 
3 h) without complication. Twelve hours after transfusion the 
packed cell volume (PCV) and total solids (TS) were 30% (RR: 
39% to 53%) and 60 g/L (RR: 60 to 80 g/dL), respectively.
The following day cystoscopy [using a 2.1 mm rigid Karl 
Storz cystoscope (Karl Storz GmbH & Co. KG, Tuttlingen, 
Baden-Württemberg, Germany)] was performed while the 
dog was anesthetized pre-anesthetic medication included 
hydromorphone (Hydromorphone HCl; Baxter Healthcare, 
Deerfield, Illinois, USA), 0.1 mg/kg body weight (BW), IM; 
induction with propofol (Propofol; Abbott Laboratories, North 
Chicago, Illinois, USA), 6 mg/kg BW, IV; general anesthesia 
was maintained with inhaled isoflurane (Isoflurane; Piramal 
Healthcare, Piramal Critical Care, Bethlehem, Pennsylvania, 
USA) and oxygen.
The ureteral orifices were normal in appearance and clear to 
yellow jets were visualized from each. The portion of the blad-
der mucosa that was visualized appeared normal and there was 
no evidence of overt bleeding, although complete visualization 
of the entire bladder mucosa was precluded due to the presence 
of large consolidated blood clots. Because a cause of the severe 
hemorrhage had not been identified and the large blood clots 
that were preventing complete visualization of the bladder wall 
could not be removed during cystoscopy, a second cystotomy 
was done (9). Several large blood clots were extracted from the 
urinary bladder and clear urine was visualized from both ureters. 
The urinary bladder and ureters were grossly normal. A bladder 
wall biopsy was collected prior to closing in a simple continuous 
and Cushing’s pattern using 3-0 PDS (PDS-II: 3-0; Ethicon, 
Somerville, New Jersey, USA). The linea alba was closed in 
a simple continuous pattern using 2-0 PDS (PDS-II:23-0; 
Ethicon), the subcutaneous layers in a continuous horizontal 
mattress pattern with 3-0 PDS, and the skin was apposed with 
adhesive tissue glue (Vetbond Tissue Adhesive; 3M Health Care, 
St. Paul, Minnesota, USA). Bladder wall histopathology revealed 
mild chronic multifocal mucosal hyperplasia.
Post-operative care included 0.45% NaCl (0.45% NaCl; 
Abbott Laboratories), 60 mL/kg BW/day, supplemented with 
potassium chloride (Potassium chloride; Hospira, Lake Forest, 
Illinois, USA), 0.05 mEq KCl/kg BW/h, fentanyl (Fentanyl; 
Hospira) continuous rate infusion (CRI), 3 mg/kg BW/h, and 
amoxicillin-clavulanic acid (Clavamox; Pfizer Animal Health, 
New York, New York, USA), 13.75 mg/kg BW, PO, q12h.
The following day the dog was bright, alert, and responsive. 
A repeat CBC disclosed a regenerative anemia (HCT 23.3%, 
262 000 reticulocytes), thrombocytosis (469 3 103/UL, RR: 190 
to 468 3 103/UL), leukocytosis (14.49 3 103/UL, RR 4.39 to 
11.61 3 103/UL), mature neutrophilia (13.62 3 103/UL, RR: 
2.84 to 9.11 3 103/UL), and lymphopenia (0.580 3 103/UL, RR: 
0.59 to 3.30 3 103/UL). A transdermal fentanyl patch (Fentanyl 
Transdermal System; Corium International, Grand Rapids, 
Michigan, USA), (50 mg) was placed and iron dextran (Iron 
Dextran; Phoenix Pharmaceuticals, St. Joseph, Missouri, USA), 
10 mg/kg BW, IM, was administered. Prior to discharge the next 
day the dog was noted to have 1 episode of passage of discolored, 
red urine. The dog was discharged from the hospital with a pre-
sumptive diagnosis of idiopathic renal hematuria and instructions 
to be given tramadol (Tramadol HCl; Amneal Pharmaceuticals, 
Glasgow, Kentucky, USA), 2 mg/kg BW, PO, q8h, ferrous sulfate 
(Ferrous sulfate; Plus Pharma, Commack, New York, New York, 
USA), 8 mg/kg BW, PO, q24h, amoxicillin-clavulanic acid, a 
transdermal fentanyl patch (50 mg/h) and famotidine (Famotidine; 
Baxter Healthcare), 1 mg/kg BW, PO, q12h.
The dog was taken to the referring veterinarian 2 d after 
discharge for malaise, pollakuria, and stranguria with passage 
of large blood clots. Focal urinary bladder ultrasound revealed 
multiple blood clots and a worsening anemia with PCV and TS 
of 20% and 65 g/L, respectively.
On return to VHC NCSU the dog’s physical examination was 
unchanged from previous assessments. On initial assessment the 
PCV and TS were 19% and 64 g/L, respectively. A major cross 
match was completed prior to a transfusion of packed RBC 
(10 mL/kg BW over 3 h). Twelve hours later PCV and TS were 
27% and 50 g/L, respectively.
A cystoscopy was repeated under general anesthesia (premedi-
cation, induction, and general anesthesia as previously described) 
revealing large organized blood clots and discolored urine jets 
from the right ureteral orifice. The dog was transferred to surgery 
for an exploratory laparotomy and cystotomy. Intraoperatively 
the ureters were catheterized towards the kidneys with a 3 French 
red rubber catheter (3 French red rubber catheter; Kendall 
Sovereign Feeding Tube 1 Urethral Catheter, Tyco Healthcare, 
Mansfield, Massachusetts, USA). The left ureter revealed gross 
hematuria. Urine from the right catheter was grossly normal and 
was collected for urinalysis which revealed microscopic hematuria 
(. 50 RBC/hpf ). A 0.5% silver nitrate solution (0.5% silver 
nitrate solution; Teva Pharmaceuticals, Sellersville, Pennsylvania, 
USA) was filtered with a 0.2 mm nylon membrane filter prior to 
injecting 1.5 mL into the left renal pelvis via the ureteral catheter. 
The left ureter was manually occluded for approximately 15 min. 
The left renal pelvis was flushed with 10 to 15 mL of sterile 0.9% 
NaCl (Hospira). The bladder and body wall closure and post-
operative care were as previously described.
The following day a transdermal fentanyl patch (50 mg/h) 
was placed and maintenance fluids (0.45% NaCl) were 
halved (30 mL/kg BW/day). A limited biochemical panel 
disclosed a decreased BUN (1.1 mmol/L), decreased creati-
nine (44.2 mmol/L), hypocalcemia (2.2 mmol/L, RR: 2.3 o 
2.9 mmol/L), hypoalbuminemia (25 g/L), hyperchloremia 
(124 mmol/L, RR: 108 to 122 mmol/L), and decreased bicar-
bonate (17 mmol/L, RR: 18 to 25.8 mmol/L). The PCV and 
TS remained stable at 34% and 64 g/L, respectively. The dog 
had one episode of passage of light pink-colored urine. A second 
limited biochemical panel disclosed hypoalbuminemia (29 g/L), 
and mild hyperkalemia (5.7 mmol/L, RR: 4 to 5.3 mmol/L). At 
the time of discharge, the urine was grossly normal and medica-
tions were as previously described.
The dog was re-evaluated 1 wk after surgery by the refer-
ring veterinarian. The PCV and TS were 37% and 72 g/L, 











 respectively. A focal urinary bladder ultrasound revealed a ven-
trally thickened bladder wall with minimal luminal debris. Urine 
via cystocentesis was cloudy with a pH of 5.0 (RR: 5.5 to 7.0), 
and hematuria (RBC . 50, RR: 0 to 3 RBC/hpf ).
One month after surgery, the owner reported no evidence 
of gross hematuria or other clinical abnormalities and the 
PCV and TS were normal at 44% and 70 g/L. Urinalysis via 
cystocentesis disclosed grossly cloudy urine, and hematuria 
(21 to 50 RBC/hpf ). The dog was administered yunnan baiyao 
(Yunnan baiyao; Activeherb Technology, San Diego, California, 
USA), 0.25 g, PO, q12h for persistent microscopic hematuria 
by the referring veterinarian.
Six months after surgery, a focal urinary ultrasound, uri-
nalysis, biochemistry panel, and PCV/TS were repeated. Both 
kidneys were unchanged in size and vascular flow; the urinary 
bladder was thickened at the apex with small amount of luminal 
debris. Renal function appeared to be normal as assessed by 
results of a serum biochemistry panel (BUN 19 mmol/L, and 
creatinine 0.7 mmol/L). Urinalysis via cystocentesis disclosed 
light red urine and hematuria (RBC . 50 RBC/hpf ). The PCV 
and TS were 48% and 80 g/L, respectively.
Ten months post-procedure the patient was presented with 
acute onset lethargy and with gross hematuria. The dog’s 
physical examination was unchanged from previous assess-
ments. Diagnostics included a CBC, limited biochemistry 
panel, and focal urinary tract ultrasound. Abnormal results 
included a regenerative anemia (HCT 29.1%; 165 000 reticulo-
cytes), increased neutrophils with a left shift (17.16 3 103/mL, 
RR: 2.84 to 9.11 3 103/mL; 1.54 3 103 band neutrophils) 
and decreased albumin (29 g/L). Ultrasound revealed a urinary 
bladder clot and mild left renal pelvic dilation with luminal 
hyperechoic debris. A laparotomy and cystotomy were repeated 
under general anesthesia (premedication, induction, and general 
anesthesia as previously described) revealing large organized 
blood clots in the bladder lumen. Both ureters were catheter-
ized as previously described. A blood clot was palpated in the 
left renal pelvis. External digital manipulation and sterile saline 
flushes were repeated but did not dislodge the clot. The 0.5% 
silver nitrate solution was injected into the left renal pelvis 
via the ureteral catheter as previously described. The bladder, 
body wall closure, and post-operative care were as previously 
prescribed and the patient was discharged from the hospital 2 d 
after surgery. At discharge the urine was grossly normal with 
intermittent organized blood clots being passed.
One week following discharge the patient was taken to the refer-
ring veterinarian for recurrent gross hematuria and dysuria. A CBC 
disclosed a regenerative anemia (HCT 12.2%; 222 000 reticu-
locytes) and a mature neutrophilia (19.15 3 103/mL). Urinary 
bladder ultrasound confirmed large blood clots within the bladder 
lumen. The dog received a pRBC transfusion (10 mL/kg BW over 
4 h) without complication prior to an exploratory laparotomy, 
selective arterial ligation (10) of the left renal artery and cystotomy. 
Active hemorrhage from either kidney was not present precluding 
arterial ligation. A left nephrectomy was performed as described 
elsewhere (11). The post-operative PCV was 22%. The kidney and 
renal pelvis were grossly normal in appearance. Histopathology of 
the left kidney revealed mild to moderate subacute neutrophilic 
and lymphocytic pyelonephritis and ureteritis with nodular glo-
merular amyloidosis.
Two days after surgery, the dog required urinary catheteriza-
tion due to urethral obstruction secondary to large blood clots. 
The PCV and TS were 16% and 50 g/L, respectively. A pRBC 
transfusion (10 mL/kg BW over 4 h) was repeated and 12 h 
post-transfusion the PCV and TS were 22% and 50 g/L, respec-
tively. The dog was administered yunnan baiyao (frequency 
increased to 0.25 g PO, q8h) and methenamine (Urex; Vatring 
Pharmaceuticals, Wytheville Virginia, USA) (10 mg/kg BW, 
PO, q6h). Gross hematuria, urethral obstruction, and blood 
loss anemia persisted for the next 24 h. The creatinine was 
increased (309 mmol/L) suspected secondary to a right ureteral 
obstruction evident on repeat urinary tract ultrasound. The dog 
was humanely euthanized with pentobarbital (Fatal Plus; Vertex 
Pharmaceutical, Cambridge, Massachusetts, USA), 1 mL/5 kg 
BW, IV, due to right renal hemorrhage that resulted in ureteral 
obstruction and subsequent azotemia. The right kidney was not 
obtained for histopathology.
Discussion
This report describes surgically assisted instillation of aseptically 
filtered 0.5% silver nitrate solution into a renal pelvis with gross 
hemorrhage via a catheterized ureter. Following instillation, 
the ureter was manually occluded to ensure contact time and 
subsequent eschar formation. This procedure is different from 
protocols reported in the human literature which describe 
installation of a 0.25% to 1.0% solution through a ureteral 
catheter placed with cystoscopic guidance. The catheter remains 
in situ up to 3 d to allow for repeated instillations (12–14). 
Fluoroscopic-guided renal pelvic installation of silver nitrate has 
been performed in veterinary medicine with reported success 
and minimal complications (15).
Silver nitrate is a cauterizing agent that coagulates cellular 
protein resulting in an eschar (12) and cessation of hemor-
rhage. Installation of silver nitrate into the urogenital tract has 
been reported in the human literature for treatment of renal 
hematuria, bladder hemorrhage, and chyluria (12,13). Reported 
complications include flank pain, nausea, vomiting, hematuria, 
acute renal and hepatic failure, and necrotizing ureteritis but are 
uncommon (12–14).
The dog in this case exhibited intermittent bleeding with its 
severity resulting in a clinical anemia requiring multiple transfu-
sions. Two cystoscopic procedures and a third cystotomy were 
initially required to confirm the kidneys as the source of the 
hemorrhage. The left kidney was determined to be the primary 
source of hemorrhage, urinary blood clots, and clinical anemia 
on the initial and subsequent evaluations; however, gross hem-
orrhage was visualized from the right ureter during cystoscopy 
prior to the patient’s first treatment but was not repeatable at 
that time or on multiple gross examinations. An intra-operative 
urinalysis at the first treatment time revealed microscopic 
hematuria. The combination of these findings is indicative of 
intermittent hemorrhage from the right kidney. The possibil-
ity of catheter-induced trauma accounting for the microscopic 
hematuria exists but is thought to be less likely given the previ-
ous cystoscopic finding of gross hemorrhage. Given the bilateral 













involvement on initial evaluation and concern for preservation 
of renal function, nephrectomy was not considered a viable 
treatment option. Both kidneys were not treated with silver 
nitrate simultaneously because there was concern that the silver 
nitrate could induce acute renal injury. Instead, the left kidney 
was chosen for treatment because that is the side that had gross 
hematuria during surgical exploration.
Ten months following the procedure, gross hematuria and 
blood loss anemia recurred. The left renal pelvic hematoma was 
suggestive that the left kidney was again the primary source of 
hemorrhage, and instillation of a 0.5% silver nitrate solution 
was repeated on the left side only. A urinalysis was not obtained 
from the right kidney to monitor for microscopic hematuria and 
the urine was grossly normal in appearance.
The transient response to the second instillation of silver 
nitrate could be a result of inadequate contact time and lack of 
eschar formation due to the large blood clot in the renal pelvis 
that could not be removed. Alternatively the presumed left-sided 
persistent bleeding could have resulted from the histologically 
confirmed subacute pyeloneophritis rather than a recurrence 
of the idiopathic hemorrhage. The pyelonephritis was either 
bacterial, secondary to contamination during the recent surgi-
cal procedure, or an expected sterile inflammatory reaction 
to the silver nitrate solution. Urine was not cultured prior to 
instillation and it is possible that bacteria smaller than the size 
restriction of the nylon membrane present in the silver nitrate 
solution could have been introduced during the procedure.
Gross examination of urine exiting the ureteral catheter 
at the time of second silver nitrate instillation and left-sided 
nephrectomy failed to reveal gross hemorrhage from either 
kidney. Given the known bilateral involvement as evident by 
gross hemorrhage visualized on cystoscopy prior to the first 
treatment and documented on urinalysis, it is plausible that the 
source of the continued bleeding was actually the right kidney 
that was not treated at any time with the silver nitrate solution. 
Due to the lack of knowledge regarding the long-term effects 
and safety of the silver nitrate solution and previous cessation 
of hemorrhage with unilateral treatment, bilateral simultaneous 
instillation was not considered to be a safe treatment option.
The dog was administered a urinary antiseptic agent, methe-
namine, prior to euthanasia. This compound is hydrolyzed to 
formaldehyde in the urine which may have pro-coagulation 
properties. The dog received the medication for less than 24 h 
prior to euthanasia and its efficacy could not be evaluated.
This case report demonstrates the importance of alternative 
treatment options for cases of idiopathic renal hematuria. As in 
this report, previous cases of bilateral renal bleeding resulted in 
death or euthanasia due to the lack of treatment options once 
a nephrectomy has been performed. The initial response to the 
chemical cauterization with silver nitrate was favorable and 
resulted in 10 mo without clinical signs or anemia.
The authors believe that the yannan baiyao administered 
did not contribute to the dog’s 10-month interval without 
gross hematuria. Following the initial treatment the dog was 
free of gross hematuria for 1 month before the yunnan baiyao 
was started by the referring veterinarian. The medication was 
administered for persistent microscopic hematuria, which was 
documented to be occurring from the untreated right kidney 
and did not resolve on subsequent urinalyses. Additionally this 
medication at increased frequency failed to resolve right-sided 
gross hemorrhage following the dogs left nephrectomy. The 
efficacy of this agent in the treatment of idiopathic renal hema-
turia is unknown. Its contribution to controlling or preventing 
recurrence of gross hemorrhage after the initial treatment cannot 
be determined in this case.
The recurrence of blood loss anemia and documented blood 
clots in bladder and ureters bolsters the possibility that the right 
kidney was the source of the hemorrhage following the second 
silver nitrate treatment. Given the intermittent nature of the 
hemorrhage from either kidney and lack of grossly visualization 
at the time of the nephrectomy, it cannot be definitively stated 
that second silver nitrate treatment was unsuccessful.
Chemical cauterization with silver nitrate solution should 
be considered a viable option for treatment of severe idiopathic 
renal hematuria. This case report demonstrates resolution of 
clinical signs and anemia for 10 months following instillation 
of a 0.5% silver nitrate solution into a grossly hemorrhaging 
renal pelvis. The efficacy of subsequent silver nitrate treatments 
cannot be fully evaluated given the known bilateral involvement. 
Additional studies exploring the efficacy, safety, and long-term 
effects of renal pelvic silver nitrate instillation are warranted. CVJ
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